PERCIVA™ ICD DR D413Recalls & reported problems
Boston Scientific Corporation · Implantable Cardioverter Defibrillator DR · Class 3 · Implant
Data updated Oct 13, 2026 from official FDA records · Editorial policy
Quick summary
This Boston Scientific PERCIVA ICD is an implanted defibrillator for the heart. Its 241 reports describe unnecessary shocks, pacing and sensing errors, and infections that led to the device being removed. The reports include 3 deaths and 146 injuries. No recalls name this device.
AI-generated from the FDA records on this page and checked automatically against the numbers below. Read the details before relying on it.
- Adverse event reports
- 248
- Deaths reported
- 3
- Injuries reported
- 148
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 248 adverse event reports that list this exact device (DI 00802526587955), received between Jul 2, 2018 and Sep 30, 2026 — classified as 3 deaths, 148 injuries, 97 malfunctions.
The most frequently reported specific device problem is “Pacing Problem” (39 reports).
14 other recalls cover devices cleared under the same FDA submission (P960040); they may or may not involve this specific model.
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.
Reports received per month
Most reported problems
Device problems
- Adverse Event Without Identified Device or Use Problem90
- Pacing Problem39
- Inappropriate/Inadequate Shock/Stimulation38
- Over-Sensing33
- High impedance25
- Under-Sensing18
- Signal Artifact/Noise15
- Premature Discharge of Battery12
Patient problems
- No Clinical Signs, Symptoms or Conditions104
- Unspecified Infection81
- Shock from Patient Lead(s)22
- Electric Shock17
- Sepsis14
- No Code Available11
- Pocket Erosion9
- No Known Impact Or Consequence To Patient4
Recent adverse event reports
The 25 most recent of 248 reports, in the reporter's own words as published by the FDA.
MalfunctionSep 30, 2026Pacing Problem; Inappropriate/Inadequate Shock/Stimulation
It was reported that this implantable cardioverter defibrillator (ICD) delivered inappropriate anti-tachycardia pacing (ATP) and an inappropriate shock. Technical Services (TS) was consulted and found the device was correctly inhibiting until the sustained rate duration was triggered. TS noted that the correlation percentage was inconsistent and low. TS recommended turning off sustained rate duration and program a lower correlation percentage. No additional adverse patient effects were reported. This ICD remains in service.
Patient problems: Shock from Patient Lead(s)
MAUDE report 50947548 ↗MalfunctionSep 30, 2026Pacing Problem; Under-Sensing
It was reported that this implantable cardioverter defibrillator (ICD) exhibited undersensing on the right atrial (RA) lead. The true R waves were blanked and pacing was delivered. Technical Services (TS) recommended reprograming for this device. This ICD remains in service. No adverse patient effects were reported.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 50947388 ↗MalfunctionSep 28, 2026Interrogation Problem
It was reported that the health care professional (HCP) had difficulties interrogating this implantable cardioverter defibrillator (ICD). Technical Services (TS) confirmed the patient had a compatible device and that the HCP was using the correct wand. The HCP mentioned they had power cycled the programmed. TS discussed going into programmer mode and then interrogating the device; the HCP was still unable to read the device. TS suspected the wand was no longer functional due to the wires in the wand. Additional information was requested but unable to be obtained at this time. No adverse patient effects were reported. This ICD remains in service.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 50913899 ↗InjurySep 24, 2026High impedance
It was reported that this implantable cardioverter defibrillator (ICD) exhibited shock impedance measurements high out of range on the right ventricular (RV) channel. Subsequently, this device was explanted and replaced. This product has not been returned for analysis. No additional adverse patient effects were reported.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 50889334 ↗InjurySep 24, 2026Inappropriate/Inadequate Shock/Stimulation
It was reported that this implantable cardioverter defibrillator (ICD) delivered inappropriate shocks for atrial tachycardia. The patient experienced several arrythmias that all appeared to be atrial driven with a total of 30 shocks delivered. The patient and their system will continue to be monitored. No additional adverse patient effects were reported. This ICD remains in service.
Patient problems: Shock from Patient Lead(s)
MAUDE report 50884315 ↗MalfunctionSep 17, 2026Device Alarm System
It was reported that the patient with this implantable cardioverter-defibrillator (ICD) stated that the device was beeping. The patient presented to the clinic, where evaluation revealed that the battery was depleted. The clinic subsequently addressed the battery anomaly. To date, this ICD remains in service. No adverse patient effects were reported.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 50798091 ↗MalfunctionSep 7, 2026Incorrect, Inadequate or Imprecise Result or Readings
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 50658332 ↗InjuryAug 19, 2026Adverse Event Without Identified Device or Use Problem
It was reported that this implantable cardioverter defibrillator (ICD) was part of a system revision due to infection. There was no additional adverse patient effects reported. The ICD was explanted.
Patient problems: Unspecified Infection
MAUDE report 50326206 ↗MalfunctionAug 13, 2026Signal Artifact/Noise; High impedance; Over-Sensing; Use of Device Problem
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 50244678 ↗MalfunctionJul 29, 2026Incorrect, Inadequate or Imprecise Result or Readings; Inappropriate/Inadequate Shock/Stimulation
Patient problems: No Clinical Signs, Symptoms or Conditions; Shock from Patient Lead(s)
MAUDE report 50077588 ↗InjuryJul 28, 2026Pacing Problem; Inappropriate/Inadequate Shock/Stimulation
It was reported that the patient with this implantable cardioverter defibrillator (ICD) received anti-tachycardia pacing (ATP) and multiple shocks for episodes of supraventricular tachycardia (SVT). Therapy was exhausted. Technical Services (TS) discussed the episode with the health care professional (HCP) and the cardiologist, which then followed up with the patient. The device appears to be functioning as programmed, and remains in service. No adverse patient effects were reported.
Patient problems: Shock from Patient Lead(s)
MAUDE report 50061594 ↗InjuryJul 7, 2026Adverse Event Without Identified Device or Use Problem
IT WAS REPORTED THAT THIS IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (ICD) WAS PART OF A SYSTEM REVISION DUE TO INFECTION. THERE WAS NO ADDITIONAL ADVERSE PATIENT EFFECTS REPORTED. THE ICD WAS EXPLANTED.
Patient problems: Unspecified Infection
MAUDE report 25741921 ↗InjuryJul 6, 2026Adverse Event Without Identified Device or Use Problem
IT WAS REPORTED THAT THIS IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (ICD) WAS PART OF A SYSTEM REVISION DUE TO INFECTION. THERE WERE NO ADDITIONAL ADVERSE PATIENT EFFECTS REPORTED. THE ICD WAS EXPLANTED.
Patient problems: Unspecified Infection
MAUDE report 25728045 ↗InjuryJul 1, 2026Pacing Problem; Inappropriate/Inadequate Shock/Stimulation
IT WAS REPORTED THAT THE PATIENT WITH THIS IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (ICD) EXPERIENCED AN ATRIAL TACHYCARDIA WITH 1:1 CONDUCTION THAT ACCELERATED INTO THE VENTRICULAR TACHYCARDIA (VT) ZONE. THE DEVICE CLASSIFIED THE RHYTHM AS VENTRICULAR TACHYCARDIA, RESULTING IN THREE INAPPROPRIATE ANTI-TACHYCARDIA PACING (ATP) THERAPIES FOLLOWED BY FOUR INAPPROPRIATE SHOCKS. THE RHYTHM REMAINED ATRIAL TACHYCARDIA WITH 1:1 CONDUCTION. THE DEVICE REMAINS IN SERVICE. NO ADVERSE PATIENT EFFECTS WERE REPORTED.
Patient problems: Shock from Patient Lead(s)
MAUDE report 25682411 ↗InjuryJun 23, 2026Adverse Event Without Identified Device or Use Problem
IT WAS REPORTED THAT THIS IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (ICD) WAS PART OF THE SYSTEM REVISION DUE TO INFECTION. NO ADVERSE PATIENT EFFECTS WERE REPORTED. THE ICD WAS EXPLANTED.
Patient problems: Unspecified Infection
MAUDE report 25595528 ↗MalfunctionJun 22, 2026Insufficient Device Problem Information
IT WAS REPORTED THAT THIS IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (ICD) SUSPECTED OF NOT WORKING. THE PATIENT ADVOCATE CONTACTED TECHNICAL SERVICES (TS) WITH QUESTIONS REGARDING DEVICE MANAGEMENT DURING A PLANNED RADIOFREQUENCY (RF) ABLATION PROCEDURE. TS REVIEWED MAGNET APPLICATION AND CAUTERY MODE AND ADVISED THAT THE ANESTHESIA TEAM CONTACT TS FOR FURTHER DISCUSSION REGARDING DEVICE MANAGEMENT DURING THE PROCEDURE. AS OF THIS TIME, THE DEVICE REMAINS IN SERVICE. NO ADVERSE PATIENT EFFECTS WERE REPORTED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 25578315 ↗InjuryJun 10, 2026Failure to Convert Rhythm
IT WAS REPORTED THAT THIS IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (ICD) SYSTEM STORED TWO VENTRICULAR EPISODES WERE APPROPRIATE TACHY THERAPY WAS DELIVERED AND THERAPY WAS EXHAUSTED DUE TO TRUE VENTRICULAR TACHYCARDIA (VT). THERAPY INTERRUPTED THE RHYTHM, HOWEVER THE ARRHYTHMIA WAS INCESSANT AND CONTINUOUS. PROGRAMMING OPTIMIZATION WAS ADVISED. THIS ICD REMAINS IN SERVICE. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 25465733 ↗MalfunctionJun 8, 2026Failure to Read Input Signal; Under-Sensing; High Capture Threshold
IT WAS REPORTED THAT THIS IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (ICD) EXHIBITED ATRIAL UNDERSENSING ON THE PRESENTING ELECTROGRAM (EGM). TECHNICAL SERVICES (TS) REVIEWED THE DEVICE DATA AND NOTED THAT THE ATRIAL SENSITIVITY WAS PROGRAMMED TO 0.2 MV WITH A MEASURED P-WAVE AMPLITUDE OF APPROXIMATELY 0.2 MV, THAT COULD POTENTIALLY CAUSED THE UNDERSENSING. ADDITIONALLY, HIGH CAPTURE THRESHOLDS WERE NOTED ON THE NON-BOSTON SCIENTIFIC RIGHT ATRIAL (RA) LEAD MEASURED AT APPROXIMATELY 4.0 V. TS PROVIDED REPROGRAMMING OPTIONS FOR ATRIAL SENSITIVITY. NO ADVERSE PATIENT EFFECTS WERE REPORTED. THIS ICD REMAINS IN SERVICE.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 25437410 ↗InjuryJun 2, 2026High impedance; Off-Label Use
IT WAS REPORTED THAT THIS IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (ICD) RECORDED HIGH IMPEDANCE MEASUREMENTS IN ALL CHANNELS DATING PRIOR TO THE EXPLANT DATE. TECHNICAL SERVICES (TS) WAS CONTACTED AND UPON REVIEWING THE DATA, NOTED THAT THIS ICD WAS TAKEN OUT OF SHIPPING MODE DAYS PRIOR TO IMPLANT WHICH IS CONSISTENT WITH HIGH IMPEDANCE MEASUREMENTS SINCE THERE WERE NO LEADS ATTACHED TO THE ICD YET. AFTER IMPLANTING, ALL MEASUREMENTS RECORDED WERE WITHIN NORMAL LIMITS. THIS ICD REMAINS IN SERVICE. NO ADVERSE PATIENT EFFECTS WERE REPORTED.
Patient problems: No Clinical Signs, Symptoms or Conditions; Unspecified Infection
MAUDE report 25368108 ↗InjuryJun 2, 2026Adverse Event Without Identified Device or Use Problem
IT WAS REPORTED THAT THE PATIENT WITH THIS IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (ICD) HAD A POCKET REVISION TO EVACUATE BLOOD CLOTS DUE TO POCKET HEMATOMA AFTER INSERTION. THIS DEVICE REMAINS IN SERVICE. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.
Patient problems: Hematoma
MAUDE report 25357384 ↗MalfunctionMay 25, 2026High impedance
IT WAS REPORTED THAT THIS IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (ICD) AND RIGHT VENTRICULAR (RV) LEAD EXHIBITED SHOCK IMPEDANCE MEASUREMENTS HIGH OUT OF RANGE. TECHNICAL SERVICES (TS) PROVIDED TROUBLESHOOTING OPTIONS. THIS ICD AND RV LEAD REMAIN IN SERVICE. NO ADVERSE PATIENT EFFECTS WERE REPORTED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 25270968 ↗InjuryMay 14, 2026Adverse Event Without Identified Device or Use Problem
IT WAS REPORTED THAT THIS IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (ICD) WAS PART OF A SYSTEM REVISION DUE TO INFECTION. THERE WERE NO ADDITIONAL ADVERSE PATIENT EFFECTS REPORTED. THE ICD WAS EXPLANTED.
Patient problems: Unspecified Infection
MAUDE report 25177219 ↗InjuryApr 17, 2026Adverse Event Without Identified Device or Use Problem
IT WAS REPORTED THAT THIS IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (ICD) WAS PART OF A SYSTEM REVISION DUE TO INFECTION. THERE WERE NO ADDITIONAL ADVERSE PATIENT EFFECTS REPORTED. THIS ICD WAS EXPLANTED.
Patient problems: Unspecified Infection
MAUDE report 24911941 ↗InjuryApr 16, 2026Adverse Event Without Identified Device or Use Problem
IT WAS REPORTED THAT THIS IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (ICD) WAS PART OF A SYSTEM REVISION DUE TO INFECTION. THERE WERE NO ADDITIONAL ADVERSE PATIENT EFFECTS REPORTED. THE ICD WAS EXPLANTED.
Patient problems: Unspecified Infection
MAUDE report 24899184 ↗InjuryMar 30, 2026Adverse Event Without Identified Device or Use Problem
IT WAS REPORTED THAT THE PATIENT WITH THIS IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (ICD) HAD HEMATOMA. THIS DEVICE WAS SURGICALLY REVISED TO REMOVE POCKET HEMATOMA AND THE DEVICE REMAINS IN SERVICE. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED. ADDITIONAL INDICATES THAT THIS ICD WAS A PART OF A FULL SYSTEM EXTRACTION DUE TO INFECTION AND A NEW ICD OF THE SAME MODEL WAS PLACED. THIS DEVICE WAS RETAINED BY THE CUSTOMER. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.
Patient problems: Hematoma; Unspecified Infection
MAUDE report 24725606 ↗
Recalls under the same FDA submission
These recalls involve devices cleared under P960040. One submission often covers many models, so check the product and lot details in each record.
- Z-1670-2022 · Jul 7, 2022 · Open, ClassifiedThe PRM is intended to be used as part of the ZOOM LATITUDE Programming System to communicate with Boston Scientific implantable pulse generators. The software in use controls all
- Z-0077-2018 · Oct 4, 2017 · TerminatedRESONATE EL ICD VR, Model D432, Sterile.
- Z-0078-2018 · Oct 4, 2017 · TerminatedRESONATE EL ICD DR, Model D433, Sterile.
- Z-0079-2018 · Oct 4, 2017 · TerminatedVIGILANT X4 CRT-D, Model G247, Sterile. Cardiac Resynchronization Therapy Defibrillators (CRT-Ds) are indicated for patients with heart failure who receive stable optimal pharma
- Z-1555-2010 · Mar 15, 2010 · TerminatedBoston Scientific CONFIENT, model E030, Implantable Cardioverter Defibrillator (ICD). The CONFIENT Implantable Cardioverter Defibrillator (ICDs) are designed to detect and termina
- Z-0610-2010 · Dec 1, 2009 · TerminatedBoston Scientific TELIGEN, Implantable Cardiac Defibrillator models E102, E110, the following models are not available in the US: models F102, F110, F111. Sterilized using ethyle
- Z-1621-2009 · Mar 4, 2009 · TerminatedGUIDANT VITALITY DS VR Model T135 VR; EL Model T127 DR; 2ICD Model T165 DR; 2ICD Model T175 VR; 2EL ICD Model T167 DR; 2 EL ICD Model T177 VR; DS Model T125 DR. Implantable Cardi
- Z-1514-2008 · Jan 7, 2008 · TerminatedVITALITY EL, models T127, T167, T177 Implantable Cardioverter Defibrillator (ICD), pulse-generator, dual Chamber
- Z-1513-2008 · Jan 7, 2008 · TerminatedVITALITY DR+ Implantable Cardioverter Defibrillator (ICD), model 1872
- Z-0050-2008 · Mar 16, 2007 · TerminatedGuidant VITALITY DS DR/VR (Models T125, T135), Guidant VITALITY EL (Model T127), Guidant VITALITY DR HE (Model T180), Implantable Cardioverter Defibrillators (ICD). Guidant Corpor
- Z-0051-2008 · Mar 16, 2007 · TerminatedGuidant VITALITY 2 DR/VR (Models T165, T175) and Guidant VITALITY 2 EL DR/VR (Models T167, T177). Implantable Cardioverter Defibrillator, ICD. Guidant Corporation, 4100 Hamline A
- Z-1297-06 · Jun 24, 2006 · TerminatedGuidant VENTAK PRIZM VR (model 1860) and VENTAK PRIZM DR (model 1861) Automatic Implantable Cardioverter Defibrillator (AICD), Dual Chamber, Sterilized with gaseous ethylene oxide.
- Z-1292-06 · May 15, 2006 · TerminatedGuidant VITALITY 2 (models T165, T175), VITALITY DS (model T125), VITALITY EL (model T135), Implantable Cardioverter Defibrillators (ICD), are designed to detect and terminate ven
- Z-0828-06 · Apr 7, 2006 · TerminatedGuidant VITALITY HE Implantable Cardioverter Defibrillator (model T180). Sterile EO. Guidant Corporation, Cardiac Rhythm Management, 4100 Hamline Avenue North, St. Paul, MN 551
Other Implantable cardioverter defibrillator (non-CRT) devices
- EMBLEM™ MRI S-ICD A219Boston Scientific Corporation · Implantable cardioverter defibrillator (non-CRT)2 recalls36 deaths15,404 reports
- EMBLEM™ S-ICD A209Boston Scientific Corporation · Implantable cardioverter defibrillator (non-CRT)1 recall7 deaths6,788 reports
- EMBLEM™ S-ICD 3501Boston Scientific Corporation · Implantable cardioverter defibrillator (non-CRT)7 deaths4,936 reports
- Cobalt™ XT DR MRI SureScan™ DDPA2D4Medtronic, Inc. · Implantable cardioverter defibrillator (non-CRT)3 recalls30 deaths1,603 reports
- ENDOTAK RELIANCE® G 0185Boston Scientific Corporation · Implantable cardioverter defibrillator (non-CRT)9 deaths1,632 reports
- VIGILANT™ EL ICD DR D233Boston Scientific Corporation · Implantable cardioverter defibrillator (non-CRT)9 deaths1,563 reports
- Evera MRI™ XT DR SureScan® DDMB1D4Medtronic, Inc. · Implantable cardioverter defibrillator (non-CRT)1 recall35 deaths1,426 reports
- Durata™ 7122St. Jude Medical, Inc. · Implantable cardioverter defibrillator (non-CRT)27 deaths1,377 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 13, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 13, 2026
- Page last rebuilt: Oct 13, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page